Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS: ELTP · Delayed Price · USD
0.185
-0.002 (-1.07%)
Jul 3, 2024, 12:55 PM EDT - Market closed
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $188.29 million as of July 3, 2024. Its market cap has increased by 1,172.23% in one year.
Market Cap
188.29M
Enterprise Value
190.36M
1-Year Change
1,172.23%
Ranking
n/a
Category
Stock Price
$0.19
Market Cap Chart
Since February 24, 2000, Elite Pharmaceuticals's market cap has increased from $114.50M to $188.29M, an increase of 64.44%. That is a compound annual growth rate of 5.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2009 | 3.50M | 66.67% |
| Dec 31, 2008 | 2.10M | -95.45% |
| Dec 31, 2007 | 46.20M | 8.71% |
| Dec 29, 2006 | 42.50M | 27.25% |
| Dec 30, 2005 | 33.40M | -24.94% |
| Dec 31, 2004 | 44.50M | 40.38% |
| Dec 31, 2003 | 31.70M | 71.35% |
| Dec 31, 2002 | 18.50M | -70.45% |
| Dec 31, 2001 | 62.60M | 12.39% |
| Dec 29, 2000 | 55.70M | -51.35% |
| Feb 24, 2000 | 114.50M | - |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |